Show simple item record

dc.contributor.author Ursu, Irina
dc.date.accessioned 2020-10-15T08:55:21Z
dc.date.available 2020-10-15T08:55:21Z
dc.date.issued 2020
dc.identifier.citation URSU, Irina. Cutaneous microbiome in rosacea. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 124. en_US
dc.identifier.uri https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/12187
dc.description Department of Dermatovenereology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020 en_US
dc.description.abstract Introduction. Rosacea, one of the most common dermatoses affecting predominantly adults between the ages of 30 and 60, is a chronic skin condition manifested by persistent Centro facial erythema, telangiectasia, papules, pustules and in advanced stages, fimes. It is divided into four subtypes - erythemothotelangiectatic, papulopustular, phytomatous and ocular. The prevalence rates are controversial, estimating affecting up to 15% of certain populations. It is more common in women, but rhinophyma is observed exclusively in men. Due to its multifactorial nature, the relapses and characteristic remissions, the diagnosis is complex. Even if there is no definitive treatment, there are effective options that can be adapted to the symptoms and severity of the disease. Aim of the study. This review of the literature has the purpose to highlight the skin microbiome and its involvement in the pathogenesis of patients with rosacea. Materials and methods. To identify relevant articles, ScienceDirect, Wiley Online Library and NCBI databases were searched using the Results. Although the concret pathogenesis of rosacea is unknown, it is assumed that this results from a combination of congenital immune system dysfunction, aberrant neurovascular signaling and dysbiosis of commensal microorganisms, all of which lead to the initiation of pro-inflammatory cascades. Considering the use of antibiotics in the treatment of rosacea, it is assumed that bacteria can be a causative factor. Studies have documented in patients with rosacea, the presence of higher concentrations of Demodex folliculorum, its role, however, is unclear and controversial. In humans, two species of Demodex are described, folliculorum (at the level of the follicular infundibulum) and brevis (at the level of the sebaceous glands), located especially on the face, scalp and upper thorax. Bacillus oleronius is also mentioned in patients with specific subtypes of rosacea, whichstimulate a strong inflammatory response, through MMP-9, TNFa and IL-8. Conclusions. Some microorganisms are mentioned as having a pathogenetic role in rosacea, but no direct correlation with the incidence of the pathology has been clearly defined. Although isolated Demodex do not appear to be the cause of rosacea, they may be an important cofactor, especially in papulopustular rosacea, by triggering a delayed hypersensitivity reaction, possibly to antigens of follicular origin, linked to Demodex folliculorum, stimulating the progression of the disease. Due to its deeper localization, Demodex brevis is more difficult to identify and that is why many studies mainly refer to Demodex folliculorum. en_US
dc.language.iso en en_US
dc.publisher MedEspera en_US
dc.subject skin microbiome en_US
dc.subject rosacea en_US
dc.subject demodex en_US
dc.title Cutaneous microbiome in rosacea en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2020
    The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics